PRGO Perrigo Company

  • STOCK
  • PRGO
  • Price as of: Jun 24, 06:40 PM EDT
  • $91.01
  • -$4.19
  • -4.4%
  • Industry
  • Drug related products
Share

PRGO Stock Dividend Data

Add PRGO to Watchlist
  • Dividend Yield
    0.64% Healthcare Average 1.66%
  • Annual Payout
    $0.58 Paid Quarterly
  • Payout Ratio
    7.0% EPS $8.32
  • Dividend Growth
    13 yrs Since 2003
  • Get PRGO DARS™ Rating

Looking to buy or sell PRGO?

Buy Now
Sell Now
Upcoming Dividend Payouts

PRGO Upcoming Dividend Payouts

PRGO has not yet officially announced its next dividend payout.
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for PRGO

Sign Up
Metric PRGO Rank PRGO Avg Ranking Notes
Relative Strength 1 year return is considerably higher than Benchmark/Peers/Broader Market/Analyst Expectations
Overall Yield Attractiveness Yield is considerably lower than Benchmark/Peers/Broader Market/Analyst Expectations
Dividend Reliability Payout ratio is considerably higher than industry average and peers
Dividend Uptrend Dividends are above average, growing as per Benchmark/Peers/Broader Market/Analyst Expectations
Earnings Growth EPS growth is above average against Benchmark/Peers/Broader Market/Analyst Expectations
DARS Rating Sign Up For DARS Ratings
Growth History

PRGO Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
14.9% 19.0% 13 years
Reveal More Dividend Growth History for PRGO
Historical Annual Dividend Data & Growth

PRGO Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
$0.5000 2015 19.0%
$0.4200 2014 16.7%
Historical Dividend Data

PRGO Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.1450 2016-04-26 2016-05-25 2016-05-27 2016-06-14 Unknown Regular Quarter
$0.1450 2016-02-06 2016-02-24 2016-02-26 2016-03-15 Unknown Regular Quarter
$0.1250 2015-11-04 2015-11-24 2015-11-27 2015-12-15 Unknown Regular Quarter
$0.1250 2015-08-12 2015-08-26 2015-08-28 2015-09-15 Unknown Regular Quarter
$0.1250 2015-04-28 2015-05-27 2015-05-29 2015-06-16 Unknown Regular Quarter
$0.1250 2015-01-27 2015-02-25 2015-02-27 2015-03-17 Unknown Regular Quarter
$0.1050 2014-11-03 2014-11-25 2014-11-28 2014-12-16 Unknown Regular Quarter
$0.1050 2014-08-13 2014-08-27 2014-08-29 2014-09-16 Unknown Regular Quarter
$0.1050 2014-04-28 2014-05-28 2014-05-30 2014-06-17 Unknown Regular Quarter
$0.1050 2014-01-29 2014-02-26 2014-02-28 2014-03-18 Unknown Regular Quarter
$0.0900 2013-11-06 2013-11-26 2013-11-29 2013-12-17 Yes Regular Quarter
$0.0900 2013-08-14 2013-08-28 2013-08-30 2013-09-17 Yes Regular Quarter
$0.0900 2013-05-02 2013-05-29 2013-05-31 2013-06-18 Yes Regular Quarter
$0.0900 2013-01-31 2013-02-27 2013-03-01 2013-03-19 Yes Regular Quarter
$0.0900 2012-11-06 2012-11-27 2012-11-29 2012-12-17 Yes Regular Quarter
$0.0800 2012-08-15 2012-08-29 2012-08-31 2012-09-18 Yes Regular Quarter
$0.0800 2012-05-03 2012-05-30 2012-06-01 2012-06-19 Yes Regular Quarter
$0.0800 2012-02-02 2012-02-29 2012-03-02 2012-03-20 Yes Regular Quarter
$0.0800 2011-10-26 2011-11-22 2011-11-25 2011-12-13 Yes Regular Quarter
$0.0700 2011-08-11 2011-08-24 2011-08-26 2011-09-13 Yes Regular Quarter
$0.0700 2011-04-28 2011-05-25 2011-05-27 2011-06-14 Yes Regular Quarter
$0.0700 2011-01-26 2011-02-23 2011-02-25 2011-03-15 Yes Regular Quarter
$0.0700 2010-10-27 2010-11-23 2010-11-26 2010-12-14 Yes Regular Quarter
$0.0625 2010-08-11 2010-08-25 2010-08-27 2010-09-14 Yes Regular Quarter
$0.0625 2010-04-28 2010-05-26 2010-05-28 2010-06-15 Yes Regular Quarter
$0.0625 2010-01-27 2010-02-24 2010-02-26 2010-03-16 Yes Regular Quarter
$0.0625 2009-10-29 2009-11-24 2009-11-27 2009-12-15 Yes Regular Quarter
$0.0550 2009-08-13 2009-08-26 2009-08-28 2009-09-15 Yes Regular Quarter
$0.0550 2009-05-06 2009-05-27 2009-05-29 2009-06-16 Yes Regular Quarter
$0.0550 2009-01-28 2009-02-25 2009-02-27 2009-03-17 Yes Regular Quarter
$0.0550 2008-11-04 2008-11-25 2008-11-28 2008-12-16 Yes Regular Quarter
$0.0500 2008-08-13 2008-08-20 2008-08-22 2008-09-16 Yes Regular Quarter
$0.0500 2008-05-01 2008-05-21 2008-05-25 2008-06-20 Yes Regular Quarter
$0.0500 2008-02-01 2008-02-20 2008-02-22 2008-03-18 Yes Regular Quarter
$0.0500 2007-10-30 2007-11-20 2007-11-23 2007-12-18 Yes Regular Quarter
$0.0450 2007-08-16 2007-08-22 2007-08-24 2007-09-18 Yes Regular Quarter
$0.0450 2007-05-02 2007-05-23 2007-05-25 2007-06-19 Yes Regular Quarter
$0.0450 2007-02-08 2007-02-21 2007-02-23 2007-03-20 Yes Regular Quarter
$0.0450 2006-11-10 2006-11-21 2006-11-24 2006-12-19 Yes Regular Quarter
$0.0425 2006-08-11 2006-08-23 2006-08-25 2006-09-19 Yes Regular Quarter
$0.0425 2006-05-12 2006-05-24 2006-05-26 2006-06-20 Yes Regular Quarter
$0.0425 2006-02-15 2006-02-22 2006-02-24 2006-03-21 Yes Regular Quarter
$0.0425 2005-10-28 2005-11-22 2005-11-25 2005-12-20 Yes Regular Quarter
$0.0400 2005-08-05 2005-08-24 2005-08-26 2005-09-20 Yes Regular Quarter
$0.0400 2005-04-22 2005-05-25 2005-05-27 2005-06-21 Yes Regular Quarter
$0.0400 2005-02-04 2005-02-23 2005-02-25 2005-03-22 Yes Regular Quarter
$0.0400 2004-10-29 2004-11-23 2004-11-26 2004-12-21 Yes Regular Quarter
$0.0350 2004-08-06 2004-08-25 2004-08-27 2004-09-21 Yes Regular Quarter
$0.0350 2004-04-30 2004-05-26 2004-05-28 2004-06-22 Yes Regular Quarter
$0.0350 2004-01-30 2004-02-25 2004-02-27 2004-03-23 Yes Regular Quarter
$0.0350 2003-10-28 2003-11-25 2003-11-28 2003-12-23 Yes Regular Quarter
$0.0250 2003-08-07 2003-08-27 2003-08-29 2003-09-23 Yes Regular Quarter
$0.0250 2003-05-09 2003-05-28 2003-05-30 2003-06-24 Yes Regular Quarter
$0.0250 2003-01-23 2003-02-26 2003-02-28 2003-03-21 Yes Regular Quarter
2-for-1 1993-07-14 1993-08-26 1993-07-29 1993-08-25 NM Stock Split NM
Company Profile

PRGO Company Profile

Exchange: NYSE
Sector: Healthcare

Perrigo Company- (PRGO)-develops, manufactures, and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products worldwide. The company operates in three segments: Consumer Healthcare, Prescription (Rx) Pharmaceuticals, and Active Pharmaceutical Ingredients (API). The company was founded in 1887 and is based in Allegan, Michigan.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks
News

Perrigo Company News

  • Earnings

    Perrigo (PRGO ) reported Q2 EPS of $2.18, $0.22 better than the analyst estimate of $1.96.

    Revenue

    Revenue for the quarter came in at $1.53 million, versus the consensus estimate of $1.52 million.

    Outlook

    Perrigo reaffirmed FY2015...

  • Earnings

    Perrigo (PRGO ) reported Q1 EPS of $1.76, 3 cents better than the analyst estimate of $1.73.

    Revenue

    Revenue for the quarter came in at $1.34 billion, versus the consensus estimate of $1.42 billion.

    Outlook

    Perrigo sees FY 2015 EPS of...

  • There are 15 major stocks going ex-dividend next week. If you buy the stock one day prior to the ex-dividend date, your name goes on the company’s record books and you receive the dividend on the record date. A stock with the least correction off...

  • So far, the second quarter hasn’t exactly been a smooth ride for investors. After starting off great, things have taken a turn for the worse. Renewed worries about the global economy have taken hold over the last few weeks, which has pushed stocks...

  • The beginning of the second quarter was full of hope when it began, especially after the poor performance during the first three months of the year. However, it looks like that hope may officially be gone. Volatility and big-time swings have come...

  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Perrigo Company...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Allstate () -...
  • Perrigo Company Q4 Profit Rises on 16% Higher Revenues; Adjusted EPS Tops Views, But Revenues Miss (PRGO)

    Before the opening bell on Thursday, pharmaceutical products manufacturer Perrigo Company (PRGO) reported a rise in its fourth quarter net income on a rise in revenues. Though the company's adjusted earnings topped estimates, its revenues missed Wall Street expectations. The Allegan, Michigan-based company posted a fourth quarter net income of $118.5 million, or $1.25 per share, up from $107.1 million, or $1.14 per share, in the same period a year ago. Excluding charges, Perrigo's adjusted net income from continuing operations for the quarter came in at $148.1 million, or $1.57 per share. According to analysts polled by Thomson Reuters, the company was expected to earn $1.56 per share in the quarter. Perrigo's quarterly net sales were $967.2 million, up about 16% from $831.8 million in revenues posted in the fourth quarter of 2012. However, analysts were expecting the company to see $999.08 million in revenues for the most recent quarter. Looking ahead and excluding the potential impact of the acquisition of Elan, Perrigo expects to report earnings between $5.51 and $5.76 per share in fiscal 2014, with adjusted earnings coming in between $6.35 and $6.60 per share. Perrigo shares were down $4.42, or 3.50%, during pre-market trading on Thursday. The stock is up 21.52% year-to-date. The Bottom Line Shares of Perrigo (PRGO) offer a 0.28% dividend yield based on last night's closing price of $126.42 and the company's annualized dividend payout of 36 cents per share. Perrigo Company (PRGO) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • Perrigo Q2 Profit Rises; Adjusted Net and Revenue Beat Wall Street View (PRGO)

    On Friday drug company Perrigo (PGRO) said that it saw a 6% increase to its second quarter earnings on higher revenues, with adjusted net income and revenue beating Wall Street expectations. The Allegan, Michigan-based company reported a fiscal second quarter net income of $105.95 million, or $1.12 per share, up from $99.74 million, or $1.06 per share, earned in the same quarter a year earlier. Adjusted earnings increased to $1.36 per share from $1.20. Analysts, according to Thomson Reuters, were expecting EPS to be $1.31. The company's net sales were up to $882.96 million from $838.17 million last year. This just beat the analyst estimate of $881.84 million in revenue for the quarter. Also announced on Friday was that Perrigo signed a agreement to acquire leading pet health product company Velcera for $160 million in cash. Looking ahead to fiscal 2013, the company is expecting EPS to be between $5.45 and $5.65 while analysts foresee EPS at $5.54. Perrigo shares were up $4.99, or +4.96%, during pre-market trading on Friday. The stock is up +4.59% over the past year. The Bottom Line Shares of Perrigo (PRGO) have a dividend yield of 0.36% based on last night's closing price of $100.51. Perrigo Company (PRGO) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • The following companies announced a change in their dividend payouts today. Companies Increasing Dividend Payouts Aaron's Inc. () has...